Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee September 17, 2014

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Otezla	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Hemangeol	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Opsumit	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Orenitram ER	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Mycamine	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Ambisome	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Brilinta	PDL Appeal	Require Prior Approval	Prior Approval Required

Footer